Activity of antifolates against Pneumocystis carinii dihydrofolate reductase and identification of a potent new agent.
Open Access
- 1 March 1987
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 165 (3), 926-931
- https://doi.org/10.1084/jem.165.3.926
Abstract
The therapy of Pneumocystis carinii (PC) pneumonia is often unsuccessful, particularly in patients with acquired immune deficiency syndrome (AIDS). Because of difficulties in growing the organism in vitro or obtaining purified organisms, current treatment choices have been made with little information on the metabolic effects of therapeutic agents on PC. This report quantitates the effects of the commonly used antifolates as well as the classic antineoplastic antifolate methotrexate and a lipid-soluble analogue, trimetrexate, on the target enzyme, dihydrofolate reductase (DHFR), in the PC organisms. Trimethoprim and pyrimethamine were found to be weak inhibitors (ID50 = 39,600 and 2,800 nM, respectively), while methotrexate and trimetrexate were potent reductase inhibitors (ID50 = 1.4 and 26.1 nM, respectively). transport studies with radiolabeled compounds showed that compounds with the classic folate structure (methotrexate and leucovorin) were not taken up by the intact PC organisms. In contrast, trimetrexate exhibited rapid uptake. These results suggest a major therapeutic advantage may be gained by combining a potent, readily transported PC DHFR inhibitor such as trimetrexate with the reduced folate leucovorin to achieve a highly potent antiprotozoan effect while preventing toxicity to mammalian cells.Keywords
This publication has 13 references indexed in Scilit:
- Dapsone-Trimethoprim for Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1986
- A re-evaluation of the competitive protein binding assay for methotrexate binding to dihydrofolate reductaseBiochemical Pharmacology, 1986
- Method of testing the susceptibility of Pneumocystis carinii to antimicrobial agents in vitroAntimicrobial Agents and Chemotherapy, 1985
- Mechanism of pyrimethamine resistance in recent isolates of Plasmodium falciparumAntimicrobial Agents and Chemotherapy, 1984
- Efficacy of diaminodiphenylsulfone and other drugs in murine Pneumocystis carinii pneumonitisAntimicrobial Agents and Chemotherapy, 1984
- Uptake and efficacy of trimetrexate (TMQ, 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl] quinazoline), a non-classical antifolate in methotrexate-resistant leukemia cells in vitroBiochemical Pharmacology, 1984
- Pneumocystis carinii Pneumonia: A Comparison Between Patients with the Acquired Immunodeficiency Syndrome and Patients with Other ImmunodeficienciesAnnals of Internal Medicine, 1984
- Transport routes utilized by L1210 cells for the influx and efflux of methotrexate.Journal of Biological Chemistry, 1984
- A simple procedure for the synthesis of high specific activity tritiated (6S)-5-formyltetrahydrofolateAnalytical Biochemistry, 1982
- Competitive protein binding assay for methotrexate.Proceedings of the National Academy of Sciences, 1975